William Grossman compensation by year
Arcus Biosciences Summary Compensation Table · all 3 fiscal years held| Component | FY2019 | FY2020 | FY2021 |
|---|---|---|---|
| Salary | $296,667 | $457,600 | $317,263 |
| Bonus | $200,000 | $0 | $0 |
| Stock awards | $0 | $3,352,750 | $688,688 |
| Option awards | $2,723,040 | $2,073,420 | $2,917,697 |
| Non-equity incentive | $180,000 | $250,000 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $600 | $1,200 | $2,900 |
| Total | $3,400,307 | $6,134,970 | $3,926,548 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Arcus Biosciences, Inc. DEF 14A filed April 20, 2022, accession 0000950170-22-005855, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Arcus Biosciences, Inc. filed document, accession 0000950170-22-005855. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2022.
Arcus Biosciences’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| Jennifer Jarrett | Chief Operating Officer | $15,520,200 |
| Terry Rosen | Chief Executive Officer | $9,480,974 |
| Juan Carlos Jaen | President and Director | $4,412,919 |
| William Grossman · this page | Former Chief Medical Officer | $3,926,548 |
| Robert Goeltz | Chief Financial Officer | $2,919,470 |
| Carolyn Tang | General Counsel | $2,916,407 |
The full Arcus Biosciences compensation record
free company briefThis page is one person within Arcus Biosciences's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Arcus Biosciences proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Arcus Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.